Cargando…
The Rac inhibitor HV-107 as a potential therapeutic for metastatic breast cancer
BACKGROUND: The significant challenge in treating triple-negative breast cancer (TNBC) lies in its high rate of distant metastasis. To address this, inhibiting metastasis formation in TNBC is vital. Rac is a key player in cancer metastasis. Previously, we developed Ehop-016, a Rac inhibitor that suc...
Autores principales: | Crespo, Grace Velez, Ortiz, Jescelica, O’Farrill, Eliud Hernández, Vlaar, Cornelis P., Inyushin, Mikhail, Kucheryavykh, Yuriy, Kucheryavykh, Lilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268403/ https://www.ncbi.nlm.nih.gov/pubmed/37316799 http://dx.doi.org/10.1186/s10020-023-00678-7 |
Ejemplares similares
-
Pyk2/FAK Signaling Is Upregulated in Recurrent Glioblastoma Tumors in a C57BL/6/GL261 Glioma Implantation Model
por: Ortiz Rivera, Jescelica, et al.
Publicado: (2023) -
Accumulation of Innate Amyloid Beta Peptide in Glioblastoma Tumors
por: Kucheryavykh, Lilia Y., et al.
Publicado: (2019) -
The PYK2 inhibitor PF-562271 enhances the effect of temozolomide on tumor growth in a C57Bl/6-Gl261 mouse glioma model
por: Ortiz-Rivera, Jescelica, et al.
Publicado: (2023) -
The Dynamics of Tumor-Infiltrating Myeloid Cell Activation and the Cytokine Expression Profile in a Glioma Resection Site during the Post-Surgical Period in Mice
por: Ortiz-Rivera, Jescelica, et al.
Publicado: (2022) -
Aβ Peptide Originated from Platelets Promises New Strategy in Anti-Alzheimer's Drug Development
por: Inyushin, Mikhail Y., et al.
Publicado: (2017)